Skip to main content
See every side of every news story
Published loading...Updated

Stopping Ozempic May Raise Heart Attack and Stroke Risk

Summary by Science Daily
A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.

4 Articles

After two years without therapy, a 22 percent higher risk of heart attack, stroke and death was recorded than in regular users.

A recent study conducted by the University of Washington in St. Louis reveals that discontinuation of treatment with GLP-1 drugs, such as Ozempic, can significantly increase the risk of cardiovascular events, such as heart attack and...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Science Daily broke the news in Encinitas, United States on Monday, September 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal